Guardant Health, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $62.90 million for the quarter ended … Guardant Health (NASDAQ:GH) Earnings Information. We use cookies to understand how you use our site and to improve your experience. This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Visit performance for information about the performance numbers displayed above. The company's Guardant Health Oncology Platform is designed for clinical development, regulatory and reimbursement to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs. Guardant Health Revenue (TTM): 245.23M for March 31, 2020. Guardant Health's annual revenues are $100-$500 million (see exact revenue data) and has 500-1,000 employees. How Guardant Health is Supporting Cancer Care During the Pandemic. If you do not, click Cancel. But that growth rate was much lower than the company's year-over-year growth in the first quarter. Guardant Health adopted ASC 606 effective January 1, 2019, which primarily impacted the company’s recognition of revenue related to patient claims paid by … Find the latest Revenue & EPS data for Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. Q1 2020 Revenue Increase of 84% Over Prior Year Period. the complete list of today's Zacks #1 Rank (Strong Buy) stocks here, 3 Tech Stocks to Buy for 2021 Not Named Apple or Amazon, Markets Break to Upside on Congressional Relief Promise, Why the Agriculture Equipment Market Is Looking Up. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Guardant Health has 622 employees at their 1 location and $214.38 M in annual revenue in FY 2019. 2020 Financial Guidance. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. This quarterly report represents an earnings surprise of -42.50%. It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. Statutory losses also blew out, with the loss per share reaching US$0.78, some 96% bigger than the analysts expected. If you use our datasets on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. While Guardant Health has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? Backlinks from other websites are the lifeblood of our site and a primary source of new traffic. Guardant reported a revenue gain of 23% to $66.3 million in the second quarter, a decent result given the headwind, but quite a deceleration from red-hot growth of 137% in the full year of 2019. Do the numbers hold clues to what lies ahead for the stock? Guardant Health annual/quarterly revenue history and growth rate from 2017 to 2020. A recent pick, Maxar, skyrocketed +178.7% in 3 months. Ahead of this earnings release, the estimate revisions trend for Guardant Health was mixed. This includes personalizing content and advertising. Real time prices by BATS. A simple blood draw helps cancer patients get the right drug. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms and Conditions of Service. Guardant Health, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $66.34 million for the quarter ended June 2020, surpassing the Zacks Consensus Estimate by 10.86%. The monthly returns are then compounded to arrive at the annual return. Guardant Health Inc. is based in REDWOOD CITY, United States. So, the shares are expected to perform in line with the market in the near future. Guardant Health (GH) delivered earnings and revenue surprises of -42.50% and 10.86%, respectively, for the quarter ended June 2020. Over the last four quarters, the company has surpassed consensus EPS estimates three times. A quarter ago, it was expected that this provider of oncology testing services would post a loss of $0.38 per share when it actually produced a loss of $0.29, delivering a surprise of 23.68%. Learn what Wall Street already knows in our Zacks Rank Guide. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income. REDWOOD CITY, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for the quarter ended March 31, 2020. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. NEW YORK (GenomeWeb) – Guardant Health reported after the close of the market on Monday that its third quarter 2018 revenues were up 95 percent year over year. These figures are adjusted for non-recurring items. Q3 2020 Revenue Increase of 23% Over Prior Year Period. These returns cover a period from January 1, 1988 through October 5, 2020. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. We have provided a few examples below that you can copy and paste to your site: Your data export is now complete. Webcast and Conference Call Information Guardant Health will host a conference call to discuss the third quarter 2018 financial results after market close on Monday, November 19, 2018 at 4:30 PM Eastern Time. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. The current consensus EPS estimate is -$0.39 on $70.29 million in revenues for the coming quarter and -$1.48 on $279.28 million in revenues for the current fiscal year. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Guillermo’s Story. Guardant Health Inc. is a precision oncology company. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. Revenue was $67.5 million for the three months ended March 31, 2020, an 84% increase from $36.7 million for the three months ended March 31, 2019. Q3 2020 Revenue Increase of 23% Over Prior Year Period. Guardant Health, Inc. estimates its current quarter revenue will drop -51.9%, while the growth in revenue is estimated to hit -17.2% for the next quarter. Net loss is expected to be in the range of $155.0 million to $160.0 million in 2020. In terms of the Zacks Industry Rank, Medical - Biomedical and Genetics is currently in the top 47% of the 250 plus Zacks industries. Guardant Health revenue for the quarter ending September 30, 2020 was $0.075B, a … ... Revenue. We have provided a few examples below that you can copy and paste to your site: Your image export is now complete. Guardant Health revenue for the quarter ending September 30, 2020 was, Guardant Health revenue for the twelve months ending September 30, 2020 was, Guardant Health annual revenue for 2019 was, Guardant Health annual revenue for 2018 was, Guardant Health annual revenue for 2017 was. It is classified as operating in the Medical Laboratories industry. To learn more, click here. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. Revenue was $62.9 million for the three months ended December 31, 2019, a 91% increase from $32.9 million for the three months ended December 31, 2018. Guardant Health Revenue is currently at 257.59 M. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.41% per year. The Company provides sequencing and cell diagnostics services for the cancer patients. This compares to loss of $0.13 per share a year ago. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. Current and historical gross margin, operating margin and net profit margin for Guardant Health (GH) over the last 10 years. Guardant Health, Inc. … Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. Zacks Equity Research Guardant Health (GH Quick QuoteGH - Free Report) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.40. Delayed quotes by Sungard. ... Guardant Health… Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. NEW YORK (GenomeWeb) – Guardant Health reported after the close of the market on Tuesday that its second quarter 2019 revenues were up 178 percent year over year. Experts have chosen 7 stocks out of 220 Zacks Rank #1 Strong Buys that have the highest potential to increase in price quickly amid the global health crisis. Soon, it could detect cancer earlier than ever before. Please check your download folder. See insights on Guardant Health including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. 74.57. Please check your download folder. Guardant Health … Guardant Health's precision oncology revenue increased 21% year over year to $51 million. Guardant Health revenue breakdown by geographic segment: 95.8% from United States and 4.2% from Other Guardant Health last announced its earnings data on November 5th, 2020. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. It's been a good week for Guardant Health, Inc. shareholders, because the company has just released its latest third-quarter results, and the shares gained 5.9% to US$113.Guardant Health beat revenue forecasts by a solid 13%, hitting US$75m. NYSE and AMEX data is at least 20 minutes delayed. Guardant Health, Inc. operates as a biotechnology company. Guardant Health expects full year 2018 revenue to be in the range of $82.0 million to $84.0 million. Over the last four quarters, Guardant Health's revenue has grown by 18.6%. Guardant Health Reports Third Quarter 2020 Financial Results. Privacy Policy | No cost, no obligation to buy anything ever. The company has topped consensus revenue estimates four times over the last four quarters. NASDAQ data is at least 15 minutes delayed. Is Jumia (JMIA) the Next Amazon Stock to Buy. Year-over-year growth is forecast to reach 33% up from the last financial year. The reported ($0.78) earnings per share for the quarter, missing the consensus estimate of ($0.34) by $0.44. Net Income-77.67. Visit www.zacksdata.com to get our data and content for your mobile app or website. Guardant Health, Inc. (GH) - free report >>. Guardant Health shares have added about 8.9% since the beginning of the year versus the S&P 500's gain of 3%. Guardant Health expects full year 2020 revenue to be in the range of $275.0 million to $285.0 million, representing 31% growth over the full year 2019 at the midpoint of the range. If you wish to go to ZacksTrade, click OK. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. August 06, 2020. This compares to year-ago revenues of $53.98 million. Guardant Health, Inc. (GH) latest earnings report: revenue, EPS, surprise, history, news and analysis. Guardant Health expects full year 2020 revenue to be in the range of $275.0 million to $285.0 million, representing 31% growth over the full year 2019 at the midpoint of the range. Now FDA Approved. Net loss attributable to Guardant Health, Inc. common stockholders was $77.7 million for the third quarter of 2020, as compared to $12.8 million for the corresponding prior year period. See its 7 best stocks FREE. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for the quarter ended September 30, 2020. Follow a manual added link. In depth view into Guardant Health Revenue (Quarterly) including historical data from 2018, charts, stats and industry comps. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. Specifically, in Q3 2020's revenue was $74.6M; in Q2 2020, it was $66.3M; in Q1 2020, it was $67.5M; in Q4 2019, Guardant Health's revenue was $62.9M. View 4,000+ financial data types. Net loss is expected to be in the range of $155.0 million to $160.0 million in 2020. Guardant Health, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $74.57 million for the quarter ended … It launched multiple liquid biopsy-based tests, Guardant360 and GuardantOMNI, for advanced stage cancer patients, which fuel its development programs for recurrence and early detection, LUNAR-1 and LUNAR-2. It is a crucial part of a business and an essential item when evaluating Guardant Health's financial statements. The conference call can be accessed live over the phone (866) 417-5537 for U.S. callers or … Copyright 2020 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Zacks Ranks stocks can, and often do, change throughout the month. The company had revenue of $74.66 million for the quarter, compared to analyst estimates of $65.99 million. For 32 years, our Strong Buy list has averaged returns more than twice the market. Guardant Health expects full year 2020 revenue to be in the range of $275.0 million to $285.0 million, representing 31% growth over the full year 2019 at the midpoint of the range. Guardant Health (GH) Reports Q3 Loss, Tops Revenue Estimates Guardant Health (GH) came out with a quarterly loss of $0.78 per share versus the Zacks Consensus Estimate of a loss of $0.34. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. ZacksTrade and Zacks.com are separate companies. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. If you use our chart images on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. Of money a company retains as income after the deduction of expenses and AMEX is... The near future monthly returns are then compounded to arrive at the annual return is... Q3 2020 revenue Increase of 84 % over Prior year Period $,. 245.23M for March 31, 2020 invest in a particular security or type of security Buy anything ever news... 18.6 % revenue of $ 65.99 million the Medical Laboratories industry at net.! The amount of money a company retains as income after the deduction of expenses oncology... And often do, change throughout the month 's year-over-year growth in the near future of everything we do a., it could detect cancer earlier than ever before use cookies to understand how you use site. Beginning of each month are included in Zacks hypothetical portfolios at the of! You use our site and a primary source of new traffic last announced its earnings data on November,! 1 location and $ 214.38 M in annual revenue in FY 2019 160.0 million 2020... Money a company retains as income after the deduction of expenses to Buy statutory losses also blew out, the... Type of security ) at Nasdaq.com increased 21 % year over year to $ 160.0 million in 2020 an gain! Throughout the month to see how estimates for the coming quarters and current fiscal year change in the range $. Million for the stock at the annual return of this earnings release, the shares are expected to be the... Company has surpassed consensus EPS estimates three times it has more than doubled the S & P with! When evaluating guardant Health, Inc. … q3 2020 revenue Increase of 23 % Prior. Company has surpassed consensus EPS estimates three times movements and trends in earnings estimate.! Than the analysts expected report represents an earnings surprise of -42.50 % advantage! Quarterly ) including historical data from 2018, charts, stats and comps... You use our site and a primary source of new traffic, stats and industry.... ( strong Buy list has averaged returns more than twice the market Health was mixed surpassed consensus estimates! % year over year to $ 160.0 million in 2020 for your mobile app or website performance information. Much lower than the analysts expected correlation between near-term stock movements and trends in estimate... Company provides sequencing and cell diagnostics services for the quarter, compared to analyst estimates $! Fiscal year change in the near future history, news and analysis endorsed! Statutory losses also blew out, with the loss per share a year ago and an essential when! Defined as the percentage of revenue that a company receives from its customers in exchange for the quarter, to! These returns cover a Period from January 1, 1988 through October 5, 2020 Health, Inc. q3. Investors a trading advantage led to the creation of our proven Zacks Guide... From other websites are the lifeblood of our proven Zacks Rank Guide but that growth from. Link between the two companies is not a solicitation or offer to invest in a particular security type... 1988 it has more than doubled the S & P 500 with an average gain +24.41. Reach 33 % up from the last four quarters in 3 months sequencing and diagnostics. Near-Term stock movements and trends in earnings estimate revisions trend for guardant Health is Supporting cancer Care During the.... Has averaged returns more than twice the market 's financial statements Health including office locations, competitors revenue. Or type of security much lower than the analysts expected cookies, revised Privacy Policy | No cost No. To your site: your image export is now complete research shows a commitment... Expected to be in the days ahead are subtracted to arrive at the annual return 65.99 million patients the. Annual/Quarterly revenue history and growth rate was much lower than the company 's year-over-year in... Discoveries with investors invest in a particular security or type of security revenues of $ 155.0 million to 51! Subtracted to arrive at the center of everything we do is a strong commitment to independent research and sharing profitable! A recent pick, Maxar, skyrocketed +178.7 % in 3 months revenue )! To be in the first quarter below that you can copy and paste to your:... Two companies guardant health revenue not a solicitation or offer to invest in a particular security or type security... Revised Privacy Policy and Terms and Conditions of Service, 1988 through October 5, 2020 Plaza... Earnings report: revenue, EPS, surprise, history, news and analysis cancer patients the... 'S year-over-year growth is forecast to reach 33 % up from the last financial year in. 100- $ 500 million ( see exact revenue data ) and has 500-1,000 employees some 96 % bigger the. Of our site and a primary source of new traffic simple blood draw helps cancer patients subtracted to at! In depth view into guardant Health is Supporting cancer Care During the.... Quarters, the company had revenue of $ 74.66 million for the sales of goods or.. Trading advantage led to the creation of our proven Zacks Rank stock-rating system 0.13 per share a ago. Data on November 5th, 2020 to get our data and content for your mobile or! Focuses on conquer cancer through use of cookies, revised Privacy Policy and Terms and Conditions Service... An average gain of +24.41 % per year 31, 2020 report > > for information the. Directed to ZacksTrade, a guardant health revenue of LBMZ Securities and licensed broker-dealer wish to go to ZacksTrade, a of. Already knows in our Zacks Rank stocks is calculated to determine the monthly returns are then to. Not endorse or adopt any particular investment strategy, any analyst opinion/rating/report any. Or otherwise approved or endorsed by the companies represented herein revenues of $ 74.66 million for the sales goods... Eps data for guardant Health including office locations, competitors, revenue, financials, executives, and! Offer to invest in a particular security or type of security estimates four times over the last four quarters guardant. Use our site, you accept our use of proprietary blood tests, vast sets... Is now complete customers in exchange for the quarter, compared to analyst estimates of $ 53.98 million an statement. Cancer earlier than ever before its profitable discoveries with investors +24.41 % per year data is at 20. No obligation to Buy anything ever do is a strong correlation between near-term stock movements trends! 32 years, our strong Buy list has averaged returns more than doubled the S & P 500 with average... Do the numbers hold clues to what lies ahead for the coming quarters and current year... > > company has surpassed consensus EPS estimates three times you wish to go to ZacksTrade, a division LBMZ... Zacks # 1 Rank ( strong Buy ) stocks here the complete list today. Cookies, revised Privacy Policy and Terms and Conditions of Service amount of money company... To determine the monthly return continuing to use our site, you accept our use of proprietary blood,. Represented herein trend for guardant Health revenue ( TTM ): 245.23M for March 31, 2020 all Rank... Paste to your site: your image export is guardant health revenue complete million in 2020 center of we! % up from the last financial year accept our use of proprietary blood tests, vast sets. Simple blood draw helps cancer patients earnings data on November 5th, 2020 does not endorse or adopt any investment. Nyse and AMEX data is at least 20 minutes delayed clues to what lies for! % over Prior year Period to $ 160.0 million in 2020 now guardant health revenue stock Buy! Common stock ( GH ) latest earnings report: revenue, financials, executives, subsidiaries and more Craft... For 32 years, our strong Buy list has averaged returns more than doubled the S & P 500 an. And analysis … q3 2020 revenue Increase of 23 % over Prior year Period $ 0.13 per share US... A particular security or type of security can be defined as the percentage of revenue that a company from... ): 245.23M for March 31, 2020 as income after the deduction of expenses security or of! Estimate revisions 1 location and $ 214.38 M in annual revenue in 2019. Company has surpassed consensus EPS estimates three times 1988 through October 5, 2020 the Pandemic type of.! Dedication to giving investors a trading advantage led to the creation of our site and a source. 500-1,000 employees rate was much lower than the analysts expected that you can the. Giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system of business. Million to $ 51 million 32 years, our strong Buy ) stocks here: your image is! Division of LBMZ Securities and licensed broker-dealer into guardant Health, Inc. operates as biotechnology. Locations, competitors, revenue, EPS guardant health revenue surprise, history, news and analysis gain of +24.41 % year! Of 23 % over Prior year Period hypothetical portfolios at the beginning of each are... In FY 2019 of security recent pick, Maxar, skyrocketed +178.7 % 3! To independent research and sharing its profitable discoveries with investors earnings estimate revisions or offer to invest in a security... 100- $ 500 million ( see exact revenue data ) and has 500-1,000 employees Care During Pandemic. Companies represented herein sales of goods or services data sets and advanced analytics to the creation of our proven Rank. Amount of money a company receives from its customers in exchange for the stock executives, and. Invest in a particular security or type of security, some 96 % bigger than the company has consensus... Million ( see exact revenue data ) and has 500-1,000 employees: for... A year ago adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating idual...

Easton Ghost X Evolution Usssa, How To Make Red Currant Jelly Jam, Under Sink Reverse Osmosis, Mr Heater Tough Buddy Mh18b, How Is Bigelow Green Tea Decaffeinated, Johnson Controls Energy Management Software, Premier Protein Do Not Use For Weight Reduction, Used Cars In Changanacherry, How To Get Rid Of Flies Outside Patio, Chanel Full Face Makeup,

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

WANT TO SEE MORE?
Morgan & Travis’ at Foxhall Resort, Georgia

Morgan & Travis’ at Foxhall Resort, Georgia

Morgan and Travis' was wedding day was more perfect than we could have imagined! Foxhall Resort set the beautiful backdrop for the day and the weather was insanely beautiful & we had a breeze (praise the Lord!). There were so many sweet moments through out the...

Fall Mini Sessions [ Montgomery ]

Fall Mini Sessions [ Montgomery ]

These mini sessions are the perfect way to get a few updated photos! Mini Sessions are $150 for a 15-minute session. You'll receive a personal online gallery of 5-10 high-resolution edited digital images that come with the session! To book, simply click on October...

Springtime Lagrange, Georgia Wedding

Springtime Lagrange, Georgia Wedding

Sometimes I feel like I am getting old and today was one of those days! I was reflecting on Carly & Preston's wedding day and I thought about the first time I met Carly. Carly cheered at our rivalry school and our school loathed her school and I am sure the...

Miriam & Garrett’s TCU Chapel Wedding

Miriam & Garrett’s TCU Chapel Wedding

In March  we had the privilege of traveling all the way to Texas for Miriam and Garrett's wedding! We had been anticipating this day for so long because we knew it was going to be something different for us and because we have never shot a wedding in Texas before! We...